Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Celsus heparin was used during the coating process manufactured from material were found to contain the contaminant over-sulfate chondroitin sulfate (oscs) mimics heparin's anticoagulant activity.